NCT05386615View on ClinicalTrials.gov

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Uterine Fibroid
Interventions
DEVICE

Body System - Functional

MR-Guided Focused Ultrasound

Trial Locations (6)

55905

RECRUITING

Mayo Clinic, Rochester

90095

RECRUITING

UCLA, Los Angeles

94305

RECRUITING

Stanford University, Stanford

Unknown

ACTIVE_NOT_RECRUITING

Huashan Hospital Affiliated to Fudan University, Shanghai

RECRUITING

Shanghai No. 1 Hospital, Shanghai

RECRUITING

Shanghai No.1 Hospital, Shanghai

Sponsors

Lead Sponsor

InSightec
All Listed Sponsors
lead

InSightec

INDUSTRY

NCT05386615 - Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids | Biotech Hunter | Biotech Hunter